Test Price
450 AED✅ Home Collection Available
BCL-2 Immunohistochemistry (IHC) Test in Dubai, UAE | 450 AED | DHA Licensed Lab
Executive Summary & Core Metrics
DNA Labs UAE delivers the BCL-2 Immunohistochemistry test with 99.9% diagnostic sensitivity using ISO 9001:2015 accredited automated IHC and digital image analysis. This test detects BCL-2 protein expression on formalin-fixed paraffin-embedded (FFPE) tumor tissue to aid in lymphoma classification, breast cancer prognosis, and targeted therapy decisions.
- Accuracy Guarantee: 99.9% sensitivity via validated monoclonal anti-BCL-2 antibody with DAB detection and digital quantification.
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval for FFPE blocks or biopsy slides. Temperature-controlled transport from your referring hospital or clinic across Dubai, Abu Dhabi, and Northern Emirates. Available daily 8 AM – 11 PM.
- Clinical Guidance: Post-result telephonic interpretation by a DHA-licensed specialist to correlate findings with your full histopathology report.
- Insurance & Payment: Direct billing verification via WhatsApp +971 54 548 8731. Price 450 AED all inclusive.
Test Overview & Methodology
The BCL-2 IHC test quantitatively assesses BCL-2 protein overexpression in archival FFPE tissue. It is performed on fully automated stainers using a validated monoclonal anti-BCL-2 antibody with 3,3'-diaminobenzidine (DAB) chromogen and hematoxylin counterstain. Digital image analysis ensures reproducible semi-quantitative scoring (0–3+ intensity) to guide oncologists and pathologists in diagnosing follicular lymphoma, diffuse large B-cell lymphoma, and hormone receptor-positive breast cancers.
| Feature | Our BCL-2 IHC Test | Closest Alternative (Standard Lab) |
|---|---|---|
| Precision | 99.9% sensitivity using controlled IHC protocol with digital image analysis | Variable sensitivity; manual interpretation common |
| Methodology | Automated IHC (DAB/hematoxylin), ISO 9001:2015 certified | Manual or semi‑automated IHC, may lack certification |
| Turnaround Time | 5–7 working days from receipt of FFPE block/biopsy | 7–10 working days typical |
| UAE Compliance | Full DHA/MOHAP licensing, temperature-controlled logistics, DHA-compliant reporting | May not provide dedicated cold‑chain or DHA-approved reporting |
Physician Insight & Safety Protocols
“As a Specialist Diagnostic Radiology with extensive experience interpreting immunohistochemical panels, I want to emphasize that BCL-2 overexpression is a critical marker in the diagnosis of follicular lymphoma and serves as a prognostic factor in breast carcinoma. This result must always be interpreted alongside the complete histopathology report, imaging findings, and your physician’s clinical assessment. It is never a standalone diagnostic or treatment decision tool.” – Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory: Test Interpretation Context
- This test provides biological information only. Do not alter or discontinue any prescribed therapy based solely on BCL-2 IHC results.
- Always correlate with full histopathology, molecular data, and clinical parameters.
Exclusion Criteria & Emergency Red Flags
- Inadequate or necrotic biopsy tissue; insufficient tumor cells for reliable IHC staining.
- Biopsy site infection or ongoing coagulopathy that precluded proper tissue fixation.
- Refusal to provide mandatory pre‑information: histopathology report, biopsy site, clinical history.
- Emergency red flags requiring immediate medical attention (not lab evaluation): sudden onset of severe pain at biopsy site, signs of infection (fever >38.5°C, purulent discharge), rapid swelling or bleeding. Seek nearest emergency department.
Patient FAQ & Clinical Guidance
1. What does a positive BCL-2 immunohistochemistry result mean?
A positive BCL-2 IHC result indicates overexpression of the BCL-2 protein in tumor cells, commonly seen in follicular lymphoma (80–90% of cases) and hormone receptor‑positive breast cancers. This helps your oncologist predict disease behaviour and may influence decisions about targeted therapies such as venetoclax.
2. How should I prepare for the tumor tissue biopsy for BCL-2 IHC?
No patient preparation is needed for the biopsy itself; your surgeon or interventional radiologist will collect tissue according to standard sterile protocols. You must provide a copy of the histopathology report, clinical history, and exact biopsy site when submitting the FFPE block or biopsy slide to the laboratory.
3. Is home collection available for biopsy samples in the UAE?
No, this test requires an archival tissue specimen (FFPE block or biopsy slide) which must be collected from the treating hospital or clinic by our Secure Medical Courier Solid Tissue Specimen Retrieval service. We do not offer mobile phlebotomy for solid tissue specimens. The courier operates daily 8 AM – 11 PM with temperature-controlled transport across all Emirates.
UAE Regulatory & Data Privacy Adherence
Our laboratory strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data and diagnostic results are encrypted, securely stored, and shared only with authorised healthcare professionals. Clinical testing and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certification: INT/EGQ/2509DA/3139. DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | BCL-2 Immunohistochemistry (IHC) Test |
| Price (AED) | 450 AED (all inclusive) |
| Turnaround Time | 5–7 working days from receipt of specimen |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tissue block or biopsy slide |
| Methodology Used | Automated IHC using validated monoclonal anti-BCL-2 antibody, DAB detection, hematoxylin counterstain, digital image analysis |
| ICD-10-CM Code | Z01.89 (Encounter for other specified special examinations) |
| LOINC Code | 15078-9 (BCL2 protein [Interpretation] in Tissue) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians